The Mystery Actor in the Neuroendocrine Theater: Who Really Knows Obestatin? Central Focus on Hypothalamic–Pituitary Axes
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26157395 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Michał Szlis und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Animal Physiology, The Kielanowski Institute of Animal Physiology and Nutrition, Polish Academy of Sciences, Instytucka 3, 05-110 Jabło…. Hauptthemen laut MEDLINE: Ghrelin, Hypothalamo-Hypophyseal System, Neurosecretory Systems. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The available literature data indicate that obestatin, a peptide derived from the preproghrelin precursor, may modulate neuroendocrine function, particularly in appetite regulation and somatotrophic/gonadotrophic pathways. This review synthesizes animal studies assessing the influence of obestatin on central neuroendocrine systems. Obestatin has been shown to affect the hypothalamic appetite-regulating center through neuropeptides such as neuropeptide Y and agouti-related peptide, yet findings remain inconsistent between species. In rodents, its effects on food intake and energy balance are inconclusive, whereas sheep models demonstrate significant alterations in orexigenic gene expression and peptide immunoreactivity. Regarding the somatotrophic axis, obestatin showed no significant effect on growth hormone (GH) secretion in rodents; however, in sheep, it modulated growth hormone-releasing hormone and somatostatin mRNA expression, elevated pituitary GH synthesis, and increased circulating GH levels. Studies involving the gonadotrophic axis demonstrated the presence of obestatin in Leydig and pituitary cells, with in vitro evidence suggesting its ability to modulate intracellular pathways implicated in gonadoliberin, luteinizing hormone, and follicle-stimulating hormone release. The collective findings discussed in this article indicate that obestatin interacts with multiple hypothalamic–pituitary axes, though its effects vary depending on species and experimental conditions. This review highlights the complexity of obestatin’s central actions and the need for further research to elucidate its functional relevance in neuroendocrine regulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Animal Physiology, The Kielanowski Institute of Animal Physiology and Nutrition, Polish Academy of Sciences, Instytucka 3, 05-110 Jabłonna, Poland.
ORCID-Profile: Michał Szlis, Anna Wójcik-Gładysz, Alina Gajewska, Bartosz Jaroslaw Przybyl
Zitieren
APA
Szlis, M., Wójcik-Gładysz, A., Gajewska, A., & Przybyl, B. J. (2025). The Mystery Actor in the Neuroendocrine Theater: Who Really Knows Obestatin? Central Focus on Hypothalamic–Pituitary Axes. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26157395
Vancouver
Szlis M, Wójcik-Gładysz A, Gajewska A, Przybyl BJ. The Mystery Actor in the Neuroendocrine Theater: Who Really Knows Obestatin? Central Focus on Hypothalamic–Pituitary Axes. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26157395
BibTeX
@article{Szlis2025,
author = {Szlis, Michał and Wójcik-Gładysz, Anna and Gajewska, Alina and Przybyl, Bartosz Jaroslaw},
title = {The Mystery Actor in the Neuroendocrine Theater: Who Really Knows Obestatin? Central Focus on Hypothalamic–Pituitary Axes},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26157395}
}
EUVIMED